Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies...
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Predicting the outcome of immunotherapy treatment in melanoma patients is challenging. Alterations in genes involved in antigen presentation and the interferon gamma (IFNγ) pathway play an important role in the immune response to tumors. We describe here that the overexpression of
PSMB8
and
PSMB9
, two major components of the immunoprot...
Alternative Titles
Full title
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c5c1da08d4014458bca5479e40d5cf1c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c5c1da08d4014458bca5479e40d5cf1c
Other Identifiers
ISSN
2041-1723
E-ISSN
2041-1723
DOI
10.1038/s41467-020-14639-9
